A 13-year-old neutered, blue-eyed female Siamese cat with a bodyweight of 4.8 kg was admitted for enucleation of the right eye. An ultrasound guided retrobulbar block with 1 mL of ropivacaine was performed under general anaesthesia. When the tip of the needle was visualised inside the intraconal space, negative aspiration of the syringe before injection and no obvious resistance during injection were confirmed. Instantly, after ropivacaine was administered, the cat became apnoeic, and its heart rate and the blood pressure increased significantly for a short period of time. During surgery, the cat needed cardiovascular support to maintain blood pressure and was under continuous mechanical ventilation. Spontaneous breathing returned 20 min after the end of anaesthesia. Brainstem anaesthesia was suspected, and after recovery, the contralateral eye was examined. A reduced menace response, horizontal nystagmus, mydriasis, and absence of the pupillary light reflex were present. The following day, mydriasis was still present, but the cat was visual and was discharged. The inadvertent intra-arterial injection of ropivacaine was suspected to be the cause of the spread into the brainstem. To the current authors’ knowledge, possible brainstem anaesthesia has only been reported in a cat 5 min after a retrobulbar block but never instantly.
19 June 2026 in Veterinary Anaesthesia and Analgesia
To evaluate whether a perioperative insulin protocol using short-acting insulin is noninferior to a biphasic, intermediate-acting insulin protocol for maintaining blood glucose (BG) within a target range of 8.3-11.1 mM in diabetic dogs undergoing phacoemulsification. Prospective, randomised, double-blinded, noninferiority clinical trial. A group of 52 client-owned diabetic dogs scheduled for phacoemulsification surgery. Dogs were randomly allocated to receive either short-acting insulin intramuscularly (NEU; n = 25) or intermediate-acting insulin subcutaneously (CAN; n = 27) on the morning of surgery. Intravenous glucose supplementation was provided based on a standardised protocol. BG was monitored for 600 minutes postinsulin injection. The primary end point was the ratio of geometric mean BG concentrations (NEU: CAN). The prespecified noninferiority margin was 1.10 (an allowable 10% increase in BG). Secondary outcomes included proportions of readings within the target range and incidence of adverse events. Noninferiority of the short-acting insulin protocol was not identified. The estimated ratio of geometric mean BG (NEU: CAN) was 1.03, with a 95% confidence interval (0.86-1.23) exceeding the noninferiority margin. High inter-individual variability was observed in both groups. The median proportion of readings within the target range was 0.11 [interquartile range (IQR) 0.08-0.23] for NEU and 0.17 (IQR: 0.08-0.29) for CAN (p = 0.413). Incidence of hypoglycaemia (BG < 3.3 mM) was low (4.0% NEU versus 11.1% CAN; p = 0.362), whereas hyperglycaemia (BG > 11.1 mM) occurred in > 96% of all dogs. Nonglycaemic complications, including hypotension (52.0% NEU versus 37.0% CAN; p = 0.402), were comparable between groups. Both protocols showed poor perioperative glycaemic control with high BG variability. These results illustrate the importance of vigilant BG monitoring with appropriate insulin or glucose supplementation during the perioperative period irrespective of insulin type.
A 2-month-old male 1.56 kg Yorkshire terrier (Case No. 1) and a 3-month-old male 2.3 kg Jack Russell Terrier (Case No. 2) were scheduled for ophthalmological surgery under general anaesthesia and neuromuscular blockade. For both patients, volume-controlled ventilation (VCV) was used with set tidal volumes (VT) of 13 mL/kg and 20 mL/kg for cases No. 1 and 2, respectively. The type of ventilator used did not take into account the intrinsic compliance of the breathing system; therefore, a significant part of the delivered VT was wasted in the expansion of the breathing system, and did not reach the patients, causing alveolar hypoventilation. Both cases developed low dynamic compliance (CD), and after a recruitment manoeuvre, EtCO2 of up to 116 mmHg and 197 mmHg were revealed for cases No. 1 and 2, respectively. The two cases had to be ventilated manually, using positive inspiratory pressures (PIP) of 20–25 mmHg, in order to improve alveolar ventilation and reduce the EtCO2, as adjustments to the VCV were ineffective. Both patients maintained an oxygen haemoglobin saturation between 94% and 100% throughout the procedure and they recovered well. Using a higher VT from the beginning, to compensate for the compliance of the breathing system, or the use of pressure-controlled ventilation (PCV), could have potentially helped to avoid these two incidences of severe hypercapnia.